NEW YORK, Sept 6 - Pharmacopeia (Nasdaq: PCOP) said Wednesday it had completed the acquisition of the software subsidiaries of Oxford Molecular Group of Oxford, UK.

The deal, which was valued at about $27 million, including cash and the assumption of certain liabilities, includes Oxford’s GCG bioinformatics software line and its RS3 cheminformatics products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.